CME

Application for CME

Accreditation by
HAAD for 7 Hours

ACROSS T2D:
Clinical Advances in Bridging
T2D and CV Disease

REGIONAL INTERCHANGE
ON DIABETES:
Simple Approaches for
Individualised T2D Management

META (Middle East, Turkey, Africa)

21-22 October, 2016
Grand Hyatt, Dubai
As a signatory of the IFPMA Code of Pharmaceutical Promotional Practices, this invitation is for healthcare
professionals only, and we would like to reiterate that when sponsoring healthcare professionals to meetings, we
cannot sponsor any family member as a companion.

Dear Doctor,
We are honored to invite you to an exciting and an interactive 2-day event that will take place in Grand Hyatt Hotel, Dubai,
United Arab Emirates on 21-22 October, 2016.
Type 2 diabetes is a chronic, progressive, and increasingly prevalent disease that is fraught with risks for the patient, frustrations for the
physician, making it a long and often difficult journey. CV disease is the underlying cause in over half of deaths in people with type 2
diabetes and is the principal cause of death in people with type 2 diabetes. CV death therefore represents a huge burden and is a key
consideration in management of type 2 diabetes. Recently, new CV outcome trial results are published, and others are upcoming in the
near future.
A comprehensive scientific agenda is prepared for the first day, in ACROSS T2D: Clinical Advances in Bridging T2D and
CV Disease, including keynote lectures, debates and panel discussions.
In the second day, the objective is to take a pragmatic approach on how T2D treatment can be further simplified with the leading
classes of current oral treatment options, in Regional Interchange on Diabetes: Simple Approaches for Individualised T2D Management.
There will be a special focus on real-life case studies as well as optimizing early patient-physician conversations.
We look forward to welcoming you in Dubai.
On behalf of Boehringer Ingelheim Regional Diabetes Team,
Ahmed Ouda, MD
Medical Team Lead

Murat Tanoren, MSc

Marketing Team Lead

LOG ONTO THE EVENT APP

Meet the right
people quickly

Share what you

know and get
involved

GET INVOLVED!
Find out practical
information
about the event

The app for live networking and interaction for your corporate events

PARTICIPATE AND CONTRIBUTE

DOWNLOAD
Evenium ConnexMe

USE THE ONLINE

WEB VERSION

http://evenium.me
iPhone / iPad

Android

Type your email address and make sure your personal

information is correct.
Enter METARID 2016 as the event code.

In the
:
You can look at slides on your device,
vote during presentations and take part by having your
comments displayed on the main screen.
MEET THE RIGHT PEOPLE
Click on the
tab to search the list of
attendees
ttendees and each ones profiles.
When on a guests profile, you will be able to
send private messages and organize meetings
and send your business card.
GET ORGANIZED
In the
: Check the event
program, the interactive map of the
event site and find practical
information.

INVITATION

Chairpersons

ACROSS T2D:
Clinical Advances in Bridging
T2D and CV Disease

Dr. Abdullah Shehab (United Arab Emirates)

Dr. Monzer Saleh (Lebanon)

Friday, 21 October 2016

Speakers

Grand Hyatt Hotel, Dubai, United Arab Emirates

Dr. Ghaida Kaddaha (United Arab Emirates)
Dr. Sanjay Kaul (United States of America)
Dr. Waqar Ahmed (Saudi Arabia)
Dr. Merlin Thomas (Australia)
Dr. Alice Cheng (Canada)

Friday, 21 October 2016

13:00

Welcome lunch

14:00

Registration

14:30

Opening

Boehringer Ingelheim

14:45

Welcome / Introduction to ACROSS T2D

Chairpersons:
Dr. Abdullah Shehab (UAE)
Dr. Monzer Saleh (Lebanon)

15:00

A new arena of CV outcome trials in T2D

Dr. Ghaida Kaddaha (UAE)

15:30

Bridging T2D and CV death: EMPA-REG OUTCOME deep dive

Dr. Sanjay Kaul (USA)

16:00

EMPA-REG OUTCOME and Heart Failure

Dr. Waqar Ahmed (KSA)

16:15

Panel discussion

All speakers

16:45

Short coffee break

17:00

Renal trajectory after EMPA-REG OUTCOME

Dr. Merlin Thomas (Australia)

17:30

Potential mechanisms of glucose-lowering drugs on the

CV system: SGLT2 inhibitors and GLP-1 receptor agonists

Dr. Alice Cheng (Canada)

18:00

THE DIABATE for SGLT2 inhibitors

1. Gluco-centric approach
2. Cardio-centric approach
3. Renal-centric approach

Dr. Alice Cheng (Canada)

Dr. Sanjay Kaul (USA)
Dr. Merlin Thomas (Australia)

18:45

Panel discussion & closing remarks

All speakers

19:45

Dinner
CV: Cardiovascular T2D: Type 2 diabetes SGLT2: Sodium-glucose co-transporter 2 GLP-1: Glucagon-like peptide-1

INVITATION

Chairpersons

REGIONAL INTERCHANGE
ON DIABETES:
Simple Approaches for
Individualised T2D management

Dr. Ali Alzahrani (Kingdom of Saudi Arabia)

Dr. Salah El Ghazaly Harb (Egypt)

Saturday, 22 October 2016

Speakers

Grand Hyatt Hotel, Dubai,

United Arab Emirates

Dr. Eman Roshdy (Egypt)

Dr. Jihad Haddad (Jordan)
Dr. Alice Cheng (Canada)
Dr. Saleh Al Jaser (Kingdom of Saudi Arabia)
Dr. Sami Azar (Lebanon)
Dr. Jeffrey Wing (South Africa)
Dr. Iyad Ksseiry (United Arab Emirates)
Dr. Reem Alamoudi (Kingdom of Saudi Arabia)
Dr. Saud Al Sifri (Kingdom of Saudi Arabia)

Saturday, 22 October 2016

09:00

Welcome / Introduction

Chairpersons:
Dr. Ali Alzahrani (KSA)
Dr. Salah El Ghazaly Harb (Egypt)

09:10

Simplifying glucose control with DPP4 inhibitors: Linagliptin

Dr. Eman Roshdy (Egypt)

09:30

Why linagliptin is a simple approach in T2D management?

Dr. Jihad Haddad (Jordan)

09:50

T2D Guidelines: Changing the paradigm

Dr. Alice Cheng (Canada)

10:10

Panel discussion

All speakers

10:30

Coffee break

11:00

Simplification in the region: Real-life cases

11:30

New simple approach on removal of excess glucose:

SGLT2 inhibitors
1. Mechanism of action & efficacy
2. Safety
3. Appropriate use of empagliflozin

Dr. Jeffrey Wing (South Africa)

Dr. Iyad Ksseiry (UAE)
Dr. Reem Alamoudi (KSA)

12:30

Simple dialogue with the patient

Dr. Saud Al Sifri (KSA)

13:00

Panel discussion & closing remarks

All speakers

13:30

Lunch

DPP4: Dipeptidyl peptidase-4 T2D: Type 2 diabetes SGLT2: Sodium-glucose co-transporter 2

Dr. Saleh Al Jaser (KSA)

Dr. Sami Azar (Lebanon)

NEM/TRA-161051a

Boehringer Ingelheim Middle East & North Africa (Scientific Office)

FZ-LLC P.O. Box 507066 Level 13 & 15 Index Tower
Dubai International Financial Center (DIFC)
Dubai, United Arab Emirates
Phone: +971 4 423 0400
Fax: +971 4 423 3637
Website: www.boehringer-ingelheim.com/mena